[go: up one dir, main page]

AR003124A1 - Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal, - Google Patents

Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,

Info

Publication number
AR003124A1
AR003124A1 ARP960102631A AR10263196A AR003124A1 AR 003124 A1 AR003124 A1 AR 003124A1 AR P960102631 A ARP960102631 A AR P960102631A AR 10263196 A AR10263196 A AR 10263196A AR 003124 A1 AR003124 A1 AR 003124A1
Authority
AR
Argentina
Prior art keywords
polypeptides
seq
hsp72
pneumoniae
immunologically related
Prior art date
Application number
ARP960102631A
Other languages
English (en)
Spanish (es)
Original Assignee
Iaf Bio Vac Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/472,534 external-priority patent/US5919620A/en
Application filed by Iaf Bio Vac Inc filed Critical Iaf Bio Vac Inc
Publication of AR003124A1 publication Critical patent/AR003124A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ARP960102631A 1995-06-07 1996-05-20 Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal, AR003124A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/472,534 US5919620A (en) 1995-06-07 1995-06-07 Heat shock protein HSP72 of Streptococcus pneumoniae
US180595P 1995-08-04 1995-08-04

Publications (1)

Publication Number Publication Date
AR003124A1 true AR003124A1 (es) 1998-07-08

Family

ID=26669494

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102631A AR003124A1 (es) 1995-06-07 1996-05-20 Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,

Country Status (18)

Country Link
EP (1) EP0832238A1 (hu)
JP (1) JPH11507214A (hu)
KR (1) KR19990022742A (hu)
CN (1) CN1192241A (hu)
AP (1) AP9701163A0 (hu)
AR (1) AR003124A1 (hu)
AU (1) AU700080B2 (hu)
BR (1) BR9609399A (hu)
CA (1) CA2224015A1 (hu)
CZ (1) CZ394297A3 (hu)
EA (1) EA199800046A1 (hu)
HU (1) HUP0600442A3 (hu)
IL (1) IL118329A0 (hu)
NO (1) NO975752L (hu)
PL (1) PL323781A1 (hu)
SK (1) SK168497A3 (hu)
TR (1) TR199701537T1 (hu)
WO (1) WO1996040928A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2253252A1 (en) * 1996-05-01 1997-11-06 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
JP2002508156A (ja) * 1997-12-31 2002-03-19 ストレスジェン バイオテクノロジーズ コーポレイション Hsp60ファミリーのStreptococcus熱ショックタンパク質
US6497880B1 (en) 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
KR100802198B1 (ko) * 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
HU229968B1 (hu) 1999-03-19 2015-03-30 Smithkline Beecham Biologicals S.A Sztreptokokkusz oltóanyag
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU2005204321B2 (en) * 1999-08-19 2008-07-10 Immunobiology Limited Vaccines from Infectious Agents
GB9919734D0 (en) * 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
EP1252517A4 (en) * 2000-01-21 2004-10-20 Wistar Inst BIOCID MOLECULES, MACROMOLECULAR OBJECTIVES AND METHOD FOR THE PRODUCTION AND USE
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1294771B1 (en) 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
GB0021757D0 (en) * 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
JP4740738B2 (ja) 2002-08-02 2011-08-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
JP4579156B2 (ja) 2002-11-01 2010-11-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原組成物
EP2287311A1 (en) * 2003-03-04 2011-02-23 Intercell AG Streptococcus pyogenes antigens
EP2336357A1 (en) * 2003-04-15 2011-06-22 Intercell AG S. pneumoniae antigens
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
CN104436180B (zh) 2006-01-17 2021-08-31 阿恩·福斯格伦 新的表面外露流感嗜血菌蛋白质(蛋白质E;pE)
CN102869377A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
CN103146734B (zh) * 2013-03-12 2014-10-01 中国人民解放军军事医学科学院军事兽医研究所 抗烧烫伤感染多器官衰竭绿脓杆菌毒素疫苗
CN104001164A (zh) * 2014-04-23 2014-08-27 杭州师范大学 一种嗜水气单胞菌热激蛋白亚单位疫苗及其制备方法
CN114805567B (zh) * 2022-06-27 2022-09-16 和元生物技术(上海)股份有限公司 识别外泌体的标志蛋白hspa1a的单克隆抗体、方法和应用
CN116258247A (zh) * 2022-12-26 2023-06-13 三峡大学 一种基于SAINet神经网络模型的电力负荷预测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571538B1 (en) * 1991-02-15 1998-07-08 The Uab Research Foundation Structural gene of pneumococcal protein
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.

Also Published As

Publication number Publication date
BR9609399A (pt) 2001-08-28
TR199701537T1 (xx) 1998-03-21
EA199800046A1 (ru) 1998-06-25
EP0832238A1 (en) 1998-04-01
AU700080B2 (en) 1998-12-17
PL323781A1 (en) 1998-04-27
KR19990022742A (ko) 1999-03-25
WO1996040928A1 (en) 1996-12-19
AP9701163A0 (en) 1998-01-31
JPH11507214A (ja) 1999-06-29
CA2224015A1 (en) 1996-12-19
HUP0600442A3 (en) 2007-03-28
SK168497A3 (en) 1998-07-08
CZ394297A3 (cs) 1998-04-15
AU5682896A (en) 1996-12-30
CN1192241A (zh) 1998-09-02
NO975752D0 (no) 1997-12-05
IL118329A0 (en) 1996-09-12
HUP0600442A2 (en) 2006-08-28
NO975752L (no) 1998-02-06

Similar Documents

Publication Publication Date Title
AR003124A1 (es) Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,
BR9916477A (pt) Polinucleotìdeo isolado, polinucleotìdeo quimérico, composição de vacina e uso desta composição compreendendo os polinucleotìdeos
DE60139690D1 (de) Immunisierung gegen chlamydia pneumoniae
WO2000034317A2 (en) Method for reducing immunogenicity of proteins
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
BR9813841A (pt) Proteìna hmw da espécie chlamydia isolada, molécula de ácido nucleico isolada, vetor de expressão recombinante, célula hospedeira transformada, proteìna recombinante isolada ou fragmento ou análogo da mesma, composição imunogênica, composição antigênica, processos para produzir uma resposta imune em um animal, anti-soro, anticorpos, reagente diagnóstico, para detectar anticorpos anti-chlamydia em uma amostra de teste, para detectar a presença de chlamydia em uma amostra de teste, para prevenir, tratar ou melhorar um distúrbio relacionado com a chlamydia em um hospedeiro em necessdiade deste tratamento, e para determinar a presença de ácido nucleico codificando uma proteìna hmw ou um fragmento ou análogo da mesma em uma amostra, kits diagnósticos para detectar anticorpos para chlamydia, e para determinar a presença de ácido nucleico codificando uma proteìna hmw ou fragmento ou análogo da mesma em uma amostra, composição de vacina, e, composição farmacêutica
NL930012I1 (nl) Recombinant DNA,daarmee getransformeerde gastherenen door de gastheren geproduceerde polypeptiden; werkwijzen ter bereiding daarvan;detectiewerkwijzenonder toepassing van de polypeptiden; samenstellingen en middelen die de polypeptiden bevatten; DNS sequenties
EA199700248A1 (ru) Выделенный по существу очищенный поверхностный антиген белковой природы neisseria и фрагмент этого антигена
BR0208944A (pt) quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
JP3245298B2 (ja) 肺炎球菌表面プロテインaのエピトープ領域
JP2009542196A (ja) 小型の化膿連鎖球菌抗原およびそれらの使用
ATE360640T1 (de) Gruppe-b streptococcus polypeptide, nukleinsäure, therapeutische zusammensetzungen und impfstoffe davon
DE60120621D1 (de) Lawsonia intracellularis Impfstoff
DE69733944D1 (de) Vmp-ähnliche sequenzen von pathogener borrelia
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
EP0369825B1 (en) Streptolysin o antigen derivative, its production and uses
RU2006134631A (ru) Иммуногенные композиции против chlamidia pneumoniae
US5354846A (en) Streptolysin O antigen derivatives, its production and uses
BR9810288A (pt) Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico.
ES2110996T3 (es) Alergeno de polen de ballico.
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
CA2338886A1 (en) Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
JP2001505534A (ja) グラム陽性菌感染の治療および診断
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
AR015393A1 (es) Molecula de polinucleotido aislada, molecula de oligonucleotido que la hibrida, vector de expresion recombinante, celula hospedadora transformada,polipeptido aislado, procedimiento para prepararlo, analogos o derivados del mismo, vacuna que comprende los anteriores, vacuna de combinacion, procedimie